dihydroxyphenylalanine has been researched along with Schizophrenia in 80 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
Excerpt | Relevance | Reference |
---|---|---|
"In order to investigate possible disturbances of the blood-brain transport mechanisms of monoamine precursors in manic-depressive illness and schizophrenia, we have measured the brain arterio-venous difference of DOPA, or 5-HTP, or tyrosine and tryptophan in 36 patients, during the infusion of either L-DOPA or L-5-HTP." | 7.66 | Blood-brain movements of tryptophan and tyrosine in manic-depressive illness and schizophrenia. ( Gaillard, JM; Tissot, R, 1979) |
"Clozapine is an atypical neuroleptic medication with superior efficacy to conventional antipsychotic agents for patients with chronic, symptomatic schizophrenia." | 5.07 | The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy. ( Breier, A; Buchanan, RW; Goldstein, DS; Holmes, C; Listwak, S; Waltrip, RW, 1994) |
"In order to investigate possible disturbances of the blood-brain transport mechanisms of monoamine precursors in manic-depressive illness and schizophrenia, we have measured the brain arterio-venous difference of DOPA, or 5-HTP, or tyrosine and tryptophan in 36 patients, during the infusion of either L-DOPA or L-5-HTP." | 3.66 | Blood-brain movements of tryptophan and tyrosine in manic-depressive illness and schizophrenia. ( Gaillard, JM; Tissot, R, 1979) |
"Twelve patients with treatment-resistant schizophrenia, twelve patients with schizophrenia who had responded to antipsychotics, and twelve healthy volunteers matched for gender, age, ethnicity, weight, and cigarette smoking underwent [(18)F]-DOPA PET scanning." | 1.38 | Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. ( Demjaha, A; Howes, OD; Kapur, S; McGuire, PK; Murray, RM, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 56 (70.00) | 18.7374 |
1990's | 5 (6.25) | 18.2507 |
2000's | 7 (8.75) | 29.6817 |
2010's | 10 (12.50) | 24.3611 |
2020's | 2 (2.50) | 2.80 |
Authors | Studies |
---|---|
Sabaroedin, K | 1 |
Razi, A | 1 |
Chopra, S | 1 |
Tran, N | 2 |
Pozaruk, A | 1 |
Chen, Z | 1 |
Finlay, A | 1 |
Nelson, B | 1 |
Allott, K | 1 |
Alvarez-Jimenez, M | 1 |
Graham, J | 1 |
Yuen, HP | 1 |
Harrigan, S | 1 |
Cropley, V | 1 |
Sharma, S | 1 |
Saluja, B | 1 |
Williams, R | 1 |
Pantelis, C | 1 |
Wood, SJ | 1 |
O'Donoghue, B | 1 |
Francey, S | 1 |
McGorry, P | 1 |
Aquino, K | 1 |
Fornito, A | 1 |
Avram, M | 1 |
Brandl, F | 1 |
Knolle, F | 1 |
Cabello, J | 1 |
Leucht, C | 1 |
Scherr, M | 1 |
Mustafa, M | 1 |
Koutsouleris, N | 1 |
Leucht, S | 1 |
Ziegler, S | 1 |
Sorg, C | 1 |
Eisenberg, DP | 1 |
Yankowitz, L | 1 |
Ianni, AM | 1 |
Rubinstein, DY | 1 |
Kohn, PD | 2 |
Hegarty, CE | 1 |
Gregory, MD | 1 |
Apud, JA | 1 |
Berman, KF | 2 |
Jauhar, S | 3 |
Nour, MM | 1 |
Veronese, M | 4 |
Rogdaki, M | 2 |
Bonoldi, I | 3 |
Azis, M | 1 |
Turkheimer, F | 2 |
McGuire, P | 1 |
Young, AH | 1 |
Howes, OD | 9 |
Dahoun, T | 2 |
Pardiñas, AF | 2 |
Bloomfield, MAP | 2 |
Froudist-Walsh, S | 2 |
Nosarti, C | 1 |
Korth, C | 1 |
Hennah, W | 1 |
Walters, J | 1 |
Prata, D | 1 |
D'Ambrosio, E | 1 |
Walters, JTR | 1 |
Demjaha, A | 2 |
Egerton, A | 2 |
Murray, RM | 3 |
Kapur, S | 2 |
Stone, JM | 1 |
McGuire, PK | 5 |
Williams, M | 1 |
Ibrahim, K | 1 |
Leung, G | 1 |
Kim, E | 1 |
Beck, K | 1 |
Seo, S | 1 |
Park, JW | 1 |
Lee, JS | 1 |
Lee, YS | 1 |
Kwon, JS | 1 |
Montgomery, AJ | 1 |
Asselin, MC | 2 |
Valli, I | 2 |
Tabraham, P | 1 |
Bramon-Bosch, E | 1 |
Valmaggia, L | 1 |
Johns, L | 1 |
Broome, M | 2 |
Grasby, PM | 2 |
Fusar-Poli, P | 1 |
Allen, P | 1 |
Booij, J | 1 |
van Amelsvoort, T | 1 |
TAKESADA, M | 1 |
KAKIMOTO, Y | 1 |
SANO, I | 1 |
KANEKO, Z | 1 |
SAINTJEAN, A | 1 |
DONALD, MW | 1 |
BAN, TA | 1 |
KUEHL, FA | 2 |
HICHENS, M | 1 |
ORMOND, RE | 2 |
MEISINGER, MA | 2 |
GALE, PH | 1 |
CIRILLO, VJ | 2 |
BRINK, NG | 2 |
TURNER, WJ | 1 |
MERLIS, S | 5 |
LENZ, H | 1 |
Schönfeldt-Lecuona, C | 1 |
Juengling, FD | 1 |
Connemann, BJ | 1 |
Reske, SN | 1 |
Spitzer, M | 1 |
Kassubek, J | 1 |
McGowan, S | 1 |
Lawrence, AD | 1 |
Sales, T | 1 |
Quested, D | 1 |
Grasby, P | 1 |
Kumakura, Y | 1 |
Cumming, P | 2 |
Vernaleken, I | 1 |
Buchholz, HG | 1 |
Siessmeier, T | 1 |
Heinz, A | 1 |
Kienast, T | 1 |
Bartenstein, P | 1 |
Gründer, G | 1 |
Huttunen, J | 1 |
Heinimaa, M | 1 |
Svirskis, T | 1 |
Nyman, M | 1 |
Kajander, J | 1 |
Forsback, S | 1 |
Solin, O | 3 |
Ilonen, T | 1 |
Korkeila, J | 1 |
Ristkari, T | 1 |
McGlashan, T | 1 |
Salokangas, RK | 2 |
Hietala, J | 3 |
Krupenina, LB | 1 |
Vinogradov, MV | 1 |
Tegeler, J | 1 |
Wöller, W | 1 |
Misionzhnik, EIu | 1 |
Vertogradova, OP | 1 |
Krasnov, VN | 1 |
Salenko, BB | 1 |
Anokhina, IP | 1 |
Kogan, BM | 1 |
Young, SN | 1 |
Gauthier, S | 1 |
Chouinard, G | 2 |
Anderson, GM | 1 |
Purdy, WC | 1 |
Syvälahti, E | 2 |
Vuorio, K | 2 |
Räkköläinen, V | 2 |
Bergman, J | 2 |
Haaparanta, M | 2 |
Kuoppamäki, M | 2 |
Kirvelä, O | 1 |
Ruotsalainen, U | 2 |
Reith, J | 1 |
Benkelfat, C | 1 |
Sherwin, A | 1 |
Yasuhara, Y | 1 |
Kuwabara, H | 1 |
Andermann, F | 1 |
Bachneff, S | 1 |
Diksic, M | 1 |
Dyve, SE | 1 |
Etienne, P | 1 |
Evans, AC | 1 |
Lal, S | 1 |
Shevell, M | 1 |
Savard, G | 1 |
Wong, DF | 1 |
Gjedde, A | 1 |
Breier, A | 2 |
Buchanan, RW | 1 |
Waltrip, RW | 1 |
Listwak, S | 1 |
Holmes, C | 1 |
Goldstein, DS | 2 |
Elman, I | 1 |
Eisenhofer, G | 1 |
Folio, J | 1 |
Malhotra, AK | 1 |
Adler, CM | 1 |
Pickar, D | 1 |
Vilkman, H | 1 |
Eronen, E | 1 |
Elkashef, AM | 1 |
Doudet, D | 1 |
Bryant, T | 1 |
Cohen, RM | 1 |
Li, SH | 1 |
Wyatt, RJ | 1 |
Meyer-Lindenberg, A | 1 |
Miletich, RS | 1 |
Esposito, G | 1 |
Carson, RE | 1 |
Quarantelli, M | 1 |
Weinberger, DR | 1 |
Carlsson, A | 2 |
Mileikovskii, IuA | 1 |
Gaillard, JM | 1 |
Tissot, R | 2 |
Mato, M | 1 |
Uchiyama, Y | 1 |
Kurihara, K | 1 |
Karasawa, T | 1 |
Levin, SL | 1 |
Beaton, JM | 1 |
Fleming, P | 1 |
Makar, H | 1 |
Hunter, KR | 1 |
Hegedus, ZL | 1 |
Altschule, MD | 1 |
Nayak, U | 1 |
Roberts, E | 1 |
Keegan, DL | 1 |
Rajput, AH | 1 |
Lipton, MA | 1 |
Matthysse, S | 1 |
Stevens, J | 1 |
Wilson, K | 1 |
Foote, W | 1 |
Barchas, JD | 1 |
Ciaranello, RD | 1 |
Dominic, JA | 1 |
Deguchi, T | 1 |
Orenberg, EK | 1 |
Renson, J | 1 |
Kessler, S | 1 |
Crawford, JP | 1 |
Kanig, K | 1 |
Oesterle, W | 1 |
Klawans, HL | 1 |
Goetz, C | 1 |
Westheimer, R | 1 |
Bryson, G | 1 |
Snyder, SH | 1 |
Angrist, B | 2 |
Sathananthan, G | 3 |
Wilk, S | 1 |
Gershon, S | 3 |
Horvath, TB | 1 |
Meares, RA | 1 |
Israelstam, DM | 1 |
Yaryura-Tobias, JA | 3 |
Diamond, B | 2 |
Stancer, HC | 1 |
Angrist, BM | 1 |
Mathieu, P | 1 |
Charvet, JC | 1 |
Chazot, G | 1 |
Trouillas, P | 1 |
Inanaga, K | 2 |
Inoue, K | 1 |
Tachibana, H | 2 |
Oshima, M | 2 |
Kotorii, T | 1 |
Hökfelt, T | 1 |
Ljungdahl, A | 1 |
Fuxe, K | 1 |
Johansson, O | 1 |
Rysánek, K | 1 |
Matussek, N | 1 |
Tran-Manh, N | 1 |
Laplante, M | 2 |
Saint-Laurent, J | 1 |
LeBel, E | 2 |
Kimura, N | 1 |
Tsukue, I | 1 |
Nakamura, K | 1 |
Koketsu, K | 1 |
Persson, T | 1 |
Roos, BE | 1 |
Bruno, A | 2 |
Bruno, SC | 1 |
Wolpert, A | 1 |
Dana, L | 1 |
Bunney, WE | 1 |
Tobias, JA | 1 |
Allegranza, A | 1 |
Wagner, AF | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomised Controlled Double Blind Crossover Study of the Effect of a Single Dose of N-acetylcysteine Versus Placebo on Brain Glutamate in Patients With Psychotic Disorders[NCT02483130] | 20 participants (Actual) | Observational | 2015-06-30 | Completed | |||
Examining the Effects of Estradiol on Neural and Molecular Response to Rewards in Perimenopausal-Onset Anhedonia and Psychosis[NCT05282277] | Phase 4 | 103 participants (Anticipated) | Interventional | 2022-04-20 | Recruiting | ||
Inpatient Evaluation of Neuropsychiatric Patients[NCT00001247] | 700 participants (Anticipated) | Observational | 1989-09-15 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
9 reviews available for dihydroxyphenylalanine and Schizophrenia
Article | Year |
---|---|
Imaging as tool to investigate psychoses and antipsychotics.
Topics: Antipsychotic Agents; Diagnostic Imaging; Dihydroxyphenylalanine; Dopamine; Dopamine Plasma Membrane | 2012 |
The common pathophysiology of monaminergic psychoses: a new hypothesis.
Topics: 5-Hydroxytryptophan; Amino Acids; Biological Transport, Active; Bipolar Disorder; Blood-Brain Barrie | 1975 |
Methylation & schizophrenia.
Topics: Amines; Amino Acids; Animals; Behavior, Animal; Catecholamines; Cats; Cystathionine; Cysteine; Dihyd | 1975 |
Implications of catecholamine systems of the brain in schizophrenia.
Topics: Amphetamine; Brain; Catecholamines; Chlorpromazine; Dihydroxyphenylalanine; Dopamine; Histamine H1 A | 1974 |
[Biochemical treatment possibilities in psychoses].
Topics: Amino Acids; Ascorbic Acid; Dihydroxyphenylalanine; Humans; Methionine; Niacinamide; Nicotinic Acids | 1969 |
Pathophysiology of schizophrenia and the striatum.
Topics: Adult; Amphetamine; Animals; Basal Ganglia; Catalepsy; Caudate Nucleus; Dihydroxyphenylalanine; Dopa | 1972 |
Catecholamines in the brain as mediators of amphetamine psychosis.
Topics: Amphetamine; Animals; Antidepressive Agents; Brain Chemistry; Bromides; Catecholamines; Cats; Cocain | 1972 |
Psychopharmacology. Yesterday, today and tomorrow: a point of view.
Topics: Affective Symptoms; Amitriptyline; Antidepressive Agents; Canada; Carbonates; Depression; Dihydroxyp | 1973 |
[Relation of monoamines to mental disorders].
Topics: Amines; Animals; Bipolar Disorder; Catecholamines; Central Nervous System; Depression; Dihydroxyphen | 1970 |
9 trials available for dihydroxyphenylalanine and Schizophrenia
Article | Year |
---|---|
The effect of clozapine on plasma norepinephrine: relationship to clinical efficacy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenocorticotropic Hormone; Adult; Analysis of Variance; Clozapine; | 1994 |
Mechanism of peripheral noradrenergic stimulation by clozapine.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Catechols; Clozapine; Dihydroxyphenylalanine; Fem | 1999 |
Levodopa in drug-induced extrapyramidal disorders.
Topics: Dihydroxyphenylalanine; Extrapyramidal Tracts; Fluphenazine; Humans; Movement Disorders; Orphenadrin | 1970 |
Psychiatric manifestations of levodopa.
Topics: Adult; Affect; Clinical Trials as Topic; Depression; Dihydroxyphenylalanine; Evaluation Studies as T | 1972 |
Behavioral effects of L-dopa in schizophrenic patients.
Topics: Adult; Analysis of Variance; Behavior; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Hum | 1973 |
Response threshold to levodopa in psychiatric patients.
Topics: Adult; Brain Chemistry; Clinical Trials as Topic; Cognition Disorders; Dihydroxyphenylalanine; Dopam | 1973 |
Clinical and animal experiments concerning the function of brain catecholamines.
Topics: Animals; Antidepressive Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Ca | 1971 |
The action of L-dopa on schizophrenic patients (a preliminary report).
Topics: Adult; Clinical Trials as Topic; Dihydroxyphenylalanine; Humans; Male; Middle Aged; Placebos; Schizo | 1970 |
Effects of L-DOPA on pharmacological parkinsonism.
Topics: Adolescent; Adult; Chlorpromazine; Clinical Trials as Topic; Dihydroxyphenylalanine; Female; Haloper | 1966 |
62 other studies available for dihydroxyphenylalanine and Schizophrenia
Article | Year |
---|---|
Frontostriatothalamic effective connectivity and dopaminergic function in the psychosis continuum.
Topics: Dihydroxyphenylalanine; Dopamine; Humans; Magnetic Resonance Imaging; Neural Pathways; Psychotic Dis | 2023 |
Aberrant striatal dopamine links topographically with cortico-thalamic dysconnectivity in schizophrenia.
Topics: Adult; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Humans; Magnetic | 2020 |
Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Do | 2017 |
A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia.
Topics: Adult; Bipolar Disorder; Case-Control Studies; Cross-Sectional Studies; Dihydroxyphenylalanine; Dopa | 2017 |
The effect of the DISC1 Ser704Cys polymorphism on striatal dopamine synthesis capacity: an [18F]-DOPA PET study.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Genetic Predisposition to Disease; | 2018 |
The effect of a genetic variant at the schizophrenia associated AS3MT/BORCS7 locus on striatal dopamine function: A PET imaging study.
Topics: Adult; Chromosomes, Human, Pair 10; Corpus Striatum; Cytoskeletal Proteins; Dihydroxyphenylalanine; | 2019 |
Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.
Topics: Analysis of Variance; Antipsychotic Agents; Aspartic Acid; Dihydroxyphenylalanine; Dopamine; Female; | 2014 |
Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study.
Topics: Adult; Depressive Disorder, Major; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Female; Humans | 2013 |
Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [
Topics: Antipsychotic Agents; Biomarkers; Clozapine; Dihydroxyphenylalanine; Dopamine; Female; Humans; Male; | 2017 |
Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Topics: Adult; Brain Mapping; Cognition Disorders; Corpus Striatum; Diagnostic and Statistical Manual of Men | 2009 |
Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study.
Topics: Adult; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Frontal Lobe; Functional Laterality; Human | 2010 |
Dopamine synthesis capacity in patients with treatment-resistant schizophrenia.
Topics: Adult; Antipsychotic Agents; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Drug Resistance; Fem | 2012 |
3,4-DIMETHOXYPHENYLETHYLAMINE AND OTHER AMINES IN THE URINE OF SCHIZOPHRENIC PATIENTS.
Topics: Amines; Chlorpromazine; Chromatography; Dihydroxyphenylalanine; Dimethoxyphenylethylamine; Dopamine; | 1963 |
[THE PSYCHOPHYSIOLOGICAL EFFECTS OF METHYLDOPA].
Topics: Blood Pressure; Blood Pressure Determination; Depression; Depressive Disorder; Dihydroxyphenylalanin | 1963 |
PARA-O-METHYLATION OF DOPAMINE IN SCHIZOPHRENIC AND NORMAL INDIVIDUALS.
Topics: Chromatography; Dihydroxyphenylalanine; Dopamine; Epinephrine; Humans; Metabolism; Methylation; Nore | 1964 |
A CLINICAL TRIAL OF PARGYLINE AND DOPA IN PSYCHOTIC SUBJECTS.
Topics: Adolescent; Biomedical Research; Brain; Brain Damage, Chronic; Depression; Depressive Disorder, Majo | 1964 |
[Paper chromatographic studies on the urine of schizophrenics and healthy subjects before and after DOPA administration].
Topics: Chromatography; Chromatography, Paper; Dihydroxyphenylalanine; Healthy Volunteers; Humans; Schizophr | 1962 |
Complete dopamine D2 receptor occupancy without extrapyramidal side effects under benperidol.
Topics: Adult; Basal Ganglia; Benperidol; Carbon Radioisotopes; Clozapine; Dihydroxyphenylalanine; Dyskinesi | 2004 |
Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study.
Topics: Adult; Case-Control Studies; Cognition; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Humans; M | 2004 |
Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study.
Topics: Adult; Brain; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomogr | 2007 |
Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia.
Topics: Adult; Analysis of Variance; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Rad | 2008 |
[State of the adrenergic and cholinergic systems of schizophrenic patients during the process of psychopharmacotherapy].
Topics: Acetylcholine; Acetylcholinesterase; Adult; Antipsychotic Agents; Catecholamines; Dihydroxyphenylala | 1980 |
[Therapeutic measures in tardive dyskinesia].
Topics: Age Factors; Amantadine; Antipsychotic Agents; Baclofen; Benzodiazepines; Bromocriptine; Deanol; Dih | 1983 |
[Changes in the levels of adrenergic and serotoninergic indices in patients with depressive states].
Topics: Adolescent; Adult; Biogenic Amines; Depression; Dihydroxyphenylalanine; Dopamine; Epinephrine; Homov | 1981 |
[Various features of dopamine metabolism in schizophrenia].
Topics: Dihydroxyphenylalanine; Dopamine; Epinephrine; Homovanillic Acid; Humans; Norepinephrine; Schizophre | 1981 |
The effect of carbidopa and benserazide on human plasma 5-hydroxytryptophan levels.
Topics: 5-Hydroxytryptophan; Adult; Benserazide; Carbidopa; Chlorpromazine; Dihydroxyphenylalanine; Humans; | 1982 |
Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.
Topics: Adult; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Female; Fluorine Radioisotopes; Humans; Ma | 1995 |
Elevated dopa decarboxylase activity in living brain of patients with psychosis.
Topics: Adult; Animals; Brain; Dihydroxyphenylalanine; Dopa Decarboxylase; Epilepsy, Complex Partial; Female | 1994 |
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.
Topics: Adolescent; Adult; Corpus Striatum; Depressive Disorder; Dihydroxyphenylalanine; Dopamine; Female; F | 1999 |
6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography.
Topics: Adult; Antipsychotic Agents; Aromatic-L-Amino-Acid Decarboxylases; Brain; Case-Control Studies; Chro | 2000 |
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.
Topics: Cerebrovascular Circulation; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotop | 2002 |
[Cerebral amines].
Topics: Amines; Animals; Brain; Dihydroxyphenylalanine; Haplorhini; Humans; Mental Disorders; Mice; Neurons; | 1976 |
Does dopamine play a role in schizophrenia?
Topics: 5-Hydroxytryptophan; Acetylcholine; Adenylyl Cyclases; Adrenergic alpha-Antagonists; Animals; Brain; | 1977 |
[Excretion of catecholamines and tryptophan derivatives in schizophrenia].
Topics: Adolescent; Adult; Biogenic Amines; Dihydroxyphenylalanine; Dopamine; Epinephrine; Female; Humans; H | 1976 |
Blood-brain movements of tryptophan and tyrosine in manic-depressive illness and schizophrenia.
Topics: Adult; Bipolar Disorder; Blood-Brain Barrier; Brain; Dihydroxyphenylalanine; Humans; Middle Aged; Sc | 1979 |
Fluorescent substance in leukocytes and platelets of psychiatric patients.
Topics: Bipolar Disorder; Blood Platelets; Depression; Dihydroxyphenylalanine; Dopamine; Histocytochemistry; | 1977 |
[Stein and Wise's neurochemical model of schizophrenia].
Topics: Biogenic Amines; Brain; Brain Mapping; Catechol O-Methyltransferase; Chemical Phenomena; Chemistry; | 1977 |
Studies on rheomelanins. 3. Excessive hemolysis associated with the production of rheomelanins from L-norepinephrine, from dopamine and from L-dopa in the blood of chronic schizophrenic patients.
Topics: Chromatography, Paper; Chronic Disease; Dihydroxyphenylalanine; Dopamine; Erythrocytes; Hemolysis; H | 1971 |
Contributions of neurochemistry to neurology and psychiatry. Introduction.
Topics: Aminobutyrates; Basal Ganglia; Brain; Dihydroxyphenylalanine; Humans; Neural Inhibition; Neurotransm | 1973 |
Drug induced dystonia tarda: treatment with L-dopa.
Topics: Antipsychotic Agents; Chlorpromazine; Chronic Disease; Diazepam; Dihydroxyphenylalanine; Dystonia Mu | 1973 |
Neuropsychopharmacology of monoamines and their regulatory enzymes.
Topics: 5-Hydroxytryptophan; Amphetamine; Animals; Apomorphine; Biogenic Amines; Brain; Cocaine; Dextroamphe | 1974 |
GABA blockade, dopamine and schizophrenia: experimental studies in the cat.
Topics: Alkaloids; Aminobutyrates; Amitriptyline; Animals; Atropine; Behavior, Animal; Cats; Dextroamphetami | 1974 |
Genetic differences in mechanisms involving neuroregulators.
Topics: Adrenal Medulla; Animals; Brain; Catecholamines; Cyclic AMP; Dihydroxyphenylalanine; Dopamine; Dopam | 1974 |
Antipsychotic drugs and catecholamine synapses.
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Binding, Competitive; Brain; Catecholamines; Chlorprom | 1974 |
Dopa in parkinson's disease.
Topics: Chorea; Dihydroxyphenylalanine; Humans; Parkinson Disease; Schizophrenia | 1969 |
Biogenic amines in normal and abnormal behavioral states.
Topics: Acetylcholine; Aggression; Aminobutyrates; Arousal; Blood-Brain Barrier; Brain; Brain Stem; Catechol | 1971 |
Amphetamine psychosis: behavioral and biochemical aspects.
Topics: Adolescent; Adult; Affect; Alcoholism; Amphetamine; Brain; Cognition Disorders; Delusions; Depressio | 1974 |
The relevance of the neurophysiological concepts of excitation and inhibition to clinical psychiatry.
Topics: Acoustic Stimulation; Adolescent; Adult; Aged; Alcohol Amnestic Disorder; Anxiety; Arousal; Dihydrox | 1973 |
From medical physicist to psychopharmacologist: a neo-renaissance interdisciplinary evolution of.
Topics: Dihydroxyphenylalanine; Disulfiram; Electroconvulsive Therapy; Enzyme Induction; History, 20th Centu | 1972 |
[4-O-Methylated catecholamines: 3-hydroxy, 4-methoxyphenylacetic acid (homo-isovanillic acid, iso-HVA) in biological media: urine, cerebrospinal fluid, and brain tissue].
Topics: Animals; Azo Compounds; Brain Chemistry; Caudate Nucleus; Cerebral Cortex; Chromatography, Paper; Di | 1972 |
Effect of L-dopa in schizophrenia.
Topics: Adult; Affective Symptoms; Behavior; Cognition Disorders; Communication; Delusions; Depersonalizatio | 1972 |
Dopamine nerve terminals in the rat limbic cortex: aspects of the dopamine hypothesis of schizophrenia.
Topics: Animals; Carbidopa; Dihydroxyphenylalanine; Disulfides; Dopamine; Dopamine beta-Hydroxylase; Humans; | 1974 |
Abnormalities in 14 CO 2 production from DL-3,4-dihydroxyphenylalanine-carboxyl- 14 C in schizophrenia and parkinsonism: a preliminary report.
Topics: Carbon Dioxide; Carbon Isotopes; Cells, Cultured; Cognition Disorders; Decarboxylation; Dihydroxyphe | 1972 |
L-DOPA therapy in drug-induced parkinsonism evaluated by the method measuring the facial expression.
Topics: Adult; Dihydroxyphenylalanine; Facial Expression; Female; Humans; Male; Movement; Parkinson Disease; | 1971 |
Three cases of schizophrenia treated with L-dopa.
Topics: Adult; Autistic Disorder; Delusions; Dihydroxyphenylalanine; Drug Synergism; Female; Hallucinations; | 1971 |
Clinical and pharmacological effects of monoamine precursors or haloperidol in chronic schizophrenia.
Topics: 5-Hydroxytryptophan; Dihydroxyphenylalanine; Haloperidol; Humans; Hydroxyindoleacetic Acid; Phenylac | 1968 |
Action of L-Dopa in drug induced extrapyramidalism.
Topics: Adult; Chlorpromazine; Chronic Disease; Dihydroxyphenylalanine; Extrapyramidal Tracts; Female; Human | 1970 |
Present status of psychological reactions to L-DOPA.
Topics: Behavior; Depression; Dihydroxyphenylalanine; Humans; Parkinson Disease; Schizophrenia | 1970 |
Levodopa and schizophrenia.
Topics: Brain; Dihydroxyphenylalanine; Humans; Parkinson Disease; Psychoses, Substance-Induced; Schizophreni | 1970 |
Decarboxylation of radioactive DOPA by erythrocytes in schizophrenia.
Topics: Carbon Dioxide; Carbon Isotopes; Chemistry, Organic; Decarboxylation; Dihydroxyphenylalanine; Erythr | 1971 |
The effect of haloperidol on the urinary excretion of dopamine, homovanillic and vanilmandelic acids in schizophrenics.
Topics: Adolescent; Adult; Dihydroxyphenylalanine; Dopamine; Haloperidol; Humans; Male; Mandelic Acids; Phen | 1965 |
A further study of catecholamine omicron-methylation in schizophrenia.
Topics: Adult; Aged; Brain Chemistry; Catecholamines; Child, Preschool; Dihydroxyphenylalanine; Dopamine; Fe | 1966 |